BPC-157 Peptide may be a suitable treatment for moderate chronic joint pain , tendon injuries, and other ailments, but it is best not to go it alone
2010 Jun;62(2):199-236
The combination of BPC-157 and TB-500 is an active area of interest in regenerative peptide research, with scientists examining whether localized and systemic mechanisms produce complementary effects
doi:10.1097/NEN.0b013e3181922348 Marques-Aleixo I, Rocha-Rodrigues S, Santos-Alves E, Coxito PM, Passos E, Oliveira PJ, Magalhaes J, Ascensao A (2012) In vitro salicylate does not further impair aging-induced brain mitochondrial dysfunction
The active factor responsible for this rejuvenating effect was eventually identified as GHK-Cu
The trade-off is clear: oral supplements require months of consistent daily use to achieve what IV delivery accomplishes in a single session